THE ROLE OF CCR5 IN HCV INFECTION

被引：21

作者：

Coenen, Martin ^{[1
]}

Nattermann, Jacob ^{[1
]}

机构：

[1] Univ Bonn, Dept Internal Med 1, D-53105 Bonn, Germany

来源：

EUROPEAN JOURNAL OF MEDICAL RESEARCH | 2010年 / 15卷 / 03期

关键词：

chemokine; chemokine receptor; CCR5; HCV; immune response; HEPATITIS-C-VIRUS; T-CELL RECRUITMENT; CHEMOKINE RECEPTOR-5; IMMUNE-RESPONSE; CCR5-DELTA-32; MUTATION; ANTIVIRAL TREATMENT; HIV-1; CORECEPTOR; LIVER-DISEASE; REJECTION; IMPACT;

D O I：

10.1186/2047-783X-15-3-97

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

Efficient recruitment and activation of immuno-competent cells is crucial for an effective immune response to hepatitis C virus (HCV) infection. Chemokines and chemokine receptors have been shown to be critically involved in these processes. The CCR5 chemokine receptor is expressed on several cells of the immune system and has been suggested to influence the susceptibility to HCV infection as well as natural course and progression of hepatitis C. However, these reports are still controversial. This review will summarize and discuss the available data regarding the potential role of CCR5 and its ligands in hepatitis C.

引用

页码：97 / 101

页数：5

共 43 条

[1]

Abdi R, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133754

[2] CC-chemokine receptor 5 (CCR5) in hepatitis C - at the crossroads of the antiviral immune response? [J].

Ahlenstiel, G ;

Woitas, RP ;

Rockstroh, J ;

Spengler, U .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 53 (06) :895-898

[3] Effects of the CCR5-Δ32 mutation on antiviral treatment in chronic hepatitis C [J].

Ahlenstiel, G ;

Berg, T ;

Woitas, RP ;

Grünhage, F ;

Iwan, A ;

Hess, L ;

Brackmann, HH ;

Kupfer, B ;

Schernick, A ;

Sauerbruch, T ;

Spengler, U .

JOURNAL OF HEPATOLOGY, 2003, 39 (02) :245-252

[4] Effects of the CCR5-Δ32 Mutation on Hepatitis C Virus-Specific Immune Responses in Patients with Haemophilia [J].

Ahlenstiel, Golo ;

Woitas, Rainer P. ;

Iwan, Agathe ;

Nattermann, Jacob ;

Feldmann, Georg ;

Rockstroh, Juergen K. ;

Oldenburg, Johannes ;

Kupfer, Bernd ;

Sauerbruch, Tilman ;

Spengler, Ulrich .

IMMUNOLOGICAL INVESTIGATIONS, 2009, 38 (01) :1-13

[5]

Algood HMS, 2004, J IMMUNOL, V173, P3287

[6]

Apolinario A, 2002, AM J GASTROENTEROL, V97, P2861, DOI 10.1111/j.1572-0241.2002.07054.x

[7] Cancer and the chemokine network [J].

Balkwill, F .

NATURE REVIEWS CANCER, 2004, 4 (07) :540-550

[8] Acute humoral rejection of renal allografts in CCR5-/- recipients [J].

Bickerstaffa, A. ;

Nozaki, T. ;

Wang, J. -J. ;

Pelletier, R. ;

Hadley, G. ;

Nadasdy, G. ;

Nadasdy, T. ;

Fairchild, R. L. .

AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 (03) :557-566

[9] Genetic variability of major inflammatory mediators has no impact on the outcome of kidney transplantation [J].

Brabcova, Irena ;

Petrasek, Jan ;

Hribova, Petra ;

Hyklova, Katerina ;

Bartosova, Katerina ;

Lacha, Jiri ;

Viklicky, Ondrej .

TRANSPLANTATION, 2007, 84 (08) :1037-1044

[10] Chemokines in the pathogenesis of vascular disease [J].

Charo, IF ;

Taubman, MB .

CIRCULATION RESEARCH, 2004, 95 (09) :858-866

← 1 2 3 4 5 →